Medicare advantage: Déjà Vu all over again?

Brian Biles, Geraldine Dallek, Lauren Nicholas

Research output: Contribution to journalArticle

Abstract

The Medicare Prescription Drug, Improvement, and Modernization Act (MMA) of 2003 expands the role of private health plans in Medicare through prescription drug plans and a revised Medicare+Choice (M+C), renamed Medicare Advantage, program. This paper discusses the factors responsible for the failure of M+C to develop as intended in 1997 and analyzes the challenges for MMA implementation in light of these factors. They include making a complex program understandable to beneficiaries; addressing plans' efforts to avoid enrolling high-cost beneficiaries; ensuring stability of benefits, providers, and plans; dealing with beneficiaries enrolled in unsuitable plans; providing equity of health benefits throughout the country; and controlling overall Medicare costs.

Original languageEnglish (US)
JournalHealth Affairs
Volume23
Issue numberSUPPL. 2
DOIs
StatePublished - Jul 2004
Externally publishedYes

Fingerprint

Medicare Part C
Medicare
Medication Therapy Management
Costs and Cost Analysis
Prescription Drugs
Insurance Benefits
medication
drug
costs
health
Health
modernization
equity
act

ASJC Scopus subject areas

  • Nursing(all)
  • Health(social science)
  • Health Professions(all)
  • Health Policy

Cite this

Medicare advantage : Déjà Vu all over again? / Biles, Brian; Dallek, Geraldine; Nicholas, Lauren.

In: Health Affairs, Vol. 23, No. SUPPL. 2, 07.2004.

Research output: Contribution to journalArticle

Biles, Brian ; Dallek, Geraldine ; Nicholas, Lauren. / Medicare advantage : Déjà Vu all over again?. In: Health Affairs. 2004 ; Vol. 23, No. SUPPL. 2.
@article{87227175738e431880e69d89d3a0da17,
title = "Medicare advantage: D{\'e}j{\`a} Vu all over again?",
abstract = "The Medicare Prescription Drug, Improvement, and Modernization Act (MMA) of 2003 expands the role of private health plans in Medicare through prescription drug plans and a revised Medicare+Choice (M+C), renamed Medicare Advantage, program. This paper discusses the factors responsible for the failure of M+C to develop as intended in 1997 and analyzes the challenges for MMA implementation in light of these factors. They include making a complex program understandable to beneficiaries; addressing plans' efforts to avoid enrolling high-cost beneficiaries; ensuring stability of benefits, providers, and plans; dealing with beneficiaries enrolled in unsuitable plans; providing equity of health benefits throughout the country; and controlling overall Medicare costs.",
author = "Brian Biles and Geraldine Dallek and Lauren Nicholas",
year = "2004",
month = "7",
doi = "10.1377/hlthaff.W4.586",
language = "English (US)",
volume = "23",
journal = "Health Affairs",
issn = "0278-2715",
publisher = "Project Hope",
number = "SUPPL. 2",

}

TY - JOUR

T1 - Medicare advantage

T2 - Déjà Vu all over again?

AU - Biles, Brian

AU - Dallek, Geraldine

AU - Nicholas, Lauren

PY - 2004/7

Y1 - 2004/7

N2 - The Medicare Prescription Drug, Improvement, and Modernization Act (MMA) of 2003 expands the role of private health plans in Medicare through prescription drug plans and a revised Medicare+Choice (M+C), renamed Medicare Advantage, program. This paper discusses the factors responsible for the failure of M+C to develop as intended in 1997 and analyzes the challenges for MMA implementation in light of these factors. They include making a complex program understandable to beneficiaries; addressing plans' efforts to avoid enrolling high-cost beneficiaries; ensuring stability of benefits, providers, and plans; dealing with beneficiaries enrolled in unsuitable plans; providing equity of health benefits throughout the country; and controlling overall Medicare costs.

AB - The Medicare Prescription Drug, Improvement, and Modernization Act (MMA) of 2003 expands the role of private health plans in Medicare through prescription drug plans and a revised Medicare+Choice (M+C), renamed Medicare Advantage, program. This paper discusses the factors responsible for the failure of M+C to develop as intended in 1997 and analyzes the challenges for MMA implementation in light of these factors. They include making a complex program understandable to beneficiaries; addressing plans' efforts to avoid enrolling high-cost beneficiaries; ensuring stability of benefits, providers, and plans; dealing with beneficiaries enrolled in unsuitable plans; providing equity of health benefits throughout the country; and controlling overall Medicare costs.

UR - http://www.scopus.com/inward/record.url?scp=17144369227&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17144369227&partnerID=8YFLogxK

U2 - 10.1377/hlthaff.W4.586

DO - 10.1377/hlthaff.W4.586

M3 - Article

C2 - 15601665

AN - SCOPUS:17144369227

VL - 23

JO - Health Affairs

JF - Health Affairs

SN - 0278-2715

IS - SUPPL. 2

ER -